Bernard Reculeau

Neurokin is a venture-back bio-tech company based in Marseilles, France. Neurokin is specializing in the development of different pharmacological in vitro platforms and in vivo experimental models related to acute neurological diseases. Neurokin's major objective is to identify new CDK inhibitors as neuroprotectants. Neurokin focuses on stroke, epilepsy, cerebral hypoxia after cardiac arrest and traumatic brain injury. As of May 2009, Neurokin has identified new neuroprotective drug candidates and has brought them to the regulatory preclinical stage.

Cisbio Bioassays SAS develops immunoassays and other related pharmaceutical products. The firm specializes in anti-bodies, vitro diagnostics, and medication for various diseases such as cancer and neurodegenerative disorder. The company was founded in 1986 and is headquartered in Codolet, France.

Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA.

CIS Bio International SA engages in the distribution of radiopharmaceuticals for diagnosis and therapy. The company is headquartered in Saclay, France.